ImageneBio (IMA) Market Capitalization (2021 - 2025)

ImageneBio has disclosed Market Capitalization across 5 years of filings, most recently posting $58.8 million for Q4 2025.

• In Q4 2025, Market Capitalization fell 25.66% year-over-year to $58.8 million; the TTM figure through Dec 2025 stood at $58.8 million (down 25.66% YoY), while the FY2025 annual figure was $27.7 million, down 64.94% from the prior year.
• Market Capitalization came in at $58.8 million for Q4 2025 at ImageneBio, down from $69.5 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $503.4 million in Q2 2021 to a low of $58.8 million in Q4 2025.
• Average Market Capitalization over 5 years is $163.8 million, with a median of $102.6 million recorded in 2021.
• The largest YoY upside for Market Capitalization was 102.51% in 2022 against a maximum downside of 72.52% in 2022.
• Over 5 years, Market Capitalization stood at $350.9 million in 2021, then slumped by 72.52% to $96.4 million in 2022, then decreased by 1.43% to $95.1 million in 2023, then fell by 16.75% to $79.1 million in 2024, then retreated by 25.66% to $58.8 million in 2025.
• Per Business Quant data, the three most recent Market Capitalization figures were $58.8 million in Q4 2025, $69.5 million in Q3 2025, and $64.7 million in Q2 2025.